SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-108656
Filing Date
2016-03-15
Accepted
2016-03-15 18:47:39
Documents
1
Period of Report
2016-03-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4009
  Complete submission text file 0001209191-16-108656.txt   5441
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Issuer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O THRESHOLD PHARMACEUTICALS, INC. 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Kroll Stewart M. (Reporting) CIK: 0001634834 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32979 | Film No.: 161508233